Stereotactic Ablative Body Radiation Therapy for Primary Kidney Cancer: A 3-Dimensional Conformal Technique Associated With Low Rates of Early Toxicity-Reference-Cited by-同舟云学术

Stereotactic Ablative Body Radiation Therapy for Primary Kidney Cancer: A 3-Dimensional Conformal Technique Associated With Low Rates of Early Toxicity

Published:2014-12 Issue:5 Volume:90 Page:1061-1068
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Pham Daniel,Thompson Ann,Kron Tomas,Foroudi Farshad,Kolsky Michal Schneider,Devereux Thomas,Lim Andrew,Siva Shankar

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma;Siva;BJU International,2012

2. Stereotactic body radiation therapy: The report of AAPM Task Group 101;Benedict;Med Phys,2010

3. Stereotactic body radiotherapy. Guidelines for commissioners, providers and clinicians: A national report;Kirkbride;Clin Oncol,2011

4. The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy;Sahgal;Clinical Oncology,2012

5. Accreditation and quality assurance for radiation therapy oncology group: Multicenter clinical trials using stereotactic body radiation therapy in lung cancer;Timmerman;Acta Oncol,2006

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II;International Journal of Radiation Oncology*Biology*Physics;2024-04

2. A review of stereotactic ablative radiotherapy for nonmetastatic renal cell carcinoma;World Journal of Urology;2024-01-20

3. Kidney Cancers;Hypofractionated and Stereotactic Radiation Therapy;2024

4. Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers;Clinical Oncology;2023-12

5. Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer;European Urology;2023-09